American journal of respiratory and critical care medicine

publication venue for

Relative contribution of driving pressure and respiratory rate to mortality in ARDS depends on age. 2026
Impact of Race and Acculturation on Lung Cancer Screening Eligibility: A Multi-Center Lung Cancer Cohort Study. 2026
The Hottest Critical Care Research in the Blue Journal: Introduction to a Special Section. 2026
Clinical utility of lung biopsy in fibrotic interstitial lung disease. 2026
Breathing lessons: how Xenon magnetic resonance imaging is resolving the overlap between asthma and chronic obstructive pulmonary disease.. 212. 2026
From Crisis to Control: The Novel Use of a Vascular Plug for Refractory Airway Hemorrhage.. 211. 2025
Associations of High Attenuation Area-Related Proteomic Biomarkers with Fibrotic or Subpleural Interstitial Lung Abnormalities.. 211. 2025
Breaking Barriers: Enhancing Access, Equity, and Efficiency in Interstitial Lung Disease Clinical Trials.. 211. 2025
Metabolomic Evidence of Biological Overlap with Heart Failure with Preserved Ejection Fraction in a Subset of Pulmonary Arterial Hypertension.. 211. 2025
Post-COPD: Can Emphysema Be Repaired?. 211. 2025
Associations of Prepandemic Lung Function and Structure with COVID-19 Outcomes: The C4R Study.. 211. 2025
Assessment of Home-based Monitoring in Adults with Chronic Lung Disease: An Official American Thoracic Society Research Statement.. 211. 2025
Dysanapsis Genetic Risk Predicts Lung Function Across the Lifespan.. 210. 2024
Association Between Baseline Driving Pressure and Mortality in Very Old Patients with Acute Respiratory Distress Syndrome.. 210. 2024
Evaluation of Etomidate Use and Association with Mortality Compared with Ketamine among Critically Ill Patients.. 210. 2024
The Effect of Chronic Altitude Exposure on Chronic Obstructive Pulmonary Disease Outcomes in the SPIROMICS Cohort: An Observational Cohort Study.. 210. 2024
Preacinar Arterial Dilation Mediates Outcomes of Quantitative Interstitial Abnormalities in the COPDGene Study.. 210. 2024
The Role of Inflammation and Fibrosis in Interstitial Lung Disease Treatment Decisions.. 210. 2024
Loss of Airway Phylogenetic Diversity Is Associated with Clinical and Pathobiological Markers of Disease Development in Chronic Obstructive Pulmonary Disease.. 210. 2024
Serum Cell-Free DNA-based Detection of Mycobacterium avium Complex Infection.. 209. 2024
Early Diagnosis and Treatment of Chronic Obstructive Pulmonary Disease: The Costs and Benefits of Case Finding.. 209. 2024
Meaningful Endpoints for Idiopathic Pulmonary Fibrosis (IPF) Clinical Trials: Emphasis on 'Feels, Functions, Survives'. Report of a Collaborative Discussion in a Symposium with Direct Engagement from Representatives of Patients, Investigators, the National Institutes of Health, a Patient Advocacy Organization, and a Regulatory Agency.. 209. 2024
Temporal Trends in Mortality of Critically Ill Patients with Sepsis in the United Kingdom, 1988-2019.. 209. 2024
Pulmonary Fibrosis Stakeholder Summit: A Joint NHLBI, Three Lakes Foundation, and Pulmonary Fibrosis Foundation Workshop Report.. 209. 2024
Accounting for Competing Events When Evaluating Long-Term Outcomes in Survivors of Critical Illness.. 208. 2023
Lower Airway Dysbiosis Augments Lung Inflammatory Injury in Mild-to-Moderate Chronic Obstructive Pulmonary Disease.. 208. 2023
Investigating Associations of Omega-3 Fatty Acids, Lung Function Decline, and Airway Obstruction.. 208. 2023
A Polygenic Risk Score for Idiopathic Pulmonary Fibrosis and Interstitial Lung Abnormalities.. 208. 2023
Serial Sampling of the Small Airway Epithelium to Identify Persistent Smoking-dysregulated Genes.. 208. 2023
Validity and Reliability of the Fatigue Severity Scale in a Real-World Interstitial Lung Disease Cohort.. 208. 2023
A Unique Cellular Organization of Human Distal Airways and Its Disarray in Chronic Obstructive Pulmonary Disease.. 207. 2023
Do Thresholds for Invasive Ventilation in Hypoxemic Respiratory Failure Exist? A Cohort Study.. 207. 2023
Prevalence and Mechanisms of Mucus Accumulation in COVID-19 Lung Disease.. 206. 2022
Clinical Trial of Losartan for Pulmonary Emphysema: Pulmonary Trials Cooperative Losartan Effects on Emphysema Progression Clinical Trial.. 206. 2022
Vasculopathy and Increased Vascular Congestion in Fatal COVID-19 and Acute Respiratory Distress Syndrome.. 206. 2022
Lung Microbiota and Metabolites Collectively Associate with Clinical Outcomes in Milder Stage Chronic Obstructive Pulmonary Disease.. 206. 2022
Liberation from Invasive Mechanical Ventilation with Continued Receipt of Vasopressor Infusions.. 205. 2022
Associations of Monocyte Count and Other Immune Cell Types with Interstitial Lung Abnormalities.. 205. 2022
Race/Ethnicity, Spirometry Reference Equations, and Prediction of Incident Clinical Events: The Multi-Ethnic Study of Atherosclerosis (MESA) Lung Study.. 205. 2022
Latent Class Analysis Reveals COVID-19-related Acute Respiratory Distress Syndrome Subgroups with Differential Responses to Corticosteroids.. 204. 2021
Patient-centered Outcomes Research in Interstitial Lung Disease: An Official American Thoracic Society Research Statement.. 204. 2021
Attention to Immortal Time Bias in Critical Care Research.. 203. 2021
Informing Healthcare Decisions with Observational Research Assessing Causal Effect. An Official American Thoracic Society Research Statement.. 203. 2021
Use of Hydrocortisone, Ascorbic Acid, and Thiamine in Adults with Septic Shock.. 202. 2020
New Opioid Use after Invasive Mechanical Ventilation and Hospital Discharge.. 202. 2020
Expression of the SARS-CoV-2 ACE2 Receptor in the Human Airway Epithelium.. 202. 2020
Association of Premorbid Blood Pressure with Vasopressor Infusion Duration in Patients with Shock.. 202. 2020
Early Use of Adjunctive Therapies for Pediatric Acute Respiratory Distress Syndrome: A PARDIE Study.. 201. 2020
Hospital Preparedness for COVID-19: A Practical Guide from a Critical Care Perspective.. 201. 2020
A Human Lung Challenge Model to Evaluate the Safety and Immunogenicity of PPD and Live Bacillus Calmette-Guérin.. 201. 2020
Lung Innate Lymphoid Cell Composition Is Altered in Primary Graft Dysfunction.. 201. 2020
Overlap of Genetic Risk between Interstitial Lung Abnormalities and Idiopathic Pulmonary Fibrosis.. 200. 2019
Update in Lung Infections and Tuberculosis 2018.. 200. 2019
Design of Idiopathic Pulmonary Fibrosis Clinical Trials in the Era of Approved Therapies.. 200. 2019
Resequencing Study Confirms That Host Defense and Cell Senescence Gene Variants Contribute to the Risk of Idiopathic Pulmonary Fibrosis.. 200. 2019
Underdetection and Undertreatment of Dyspnea in Critically Ill Patients.. 199. 2019
Omega-3 Fatty Acids and Genome-Wide Interaction Analyses Reveal DPP10-Pulmonary Function Association.. 199. 2019
Albuminuria, Lung Function Decline, and Risk of Incident Chronic Obstructive Pulmonary Disease. The NHLBI Pooled Cohorts Study.. 199. 2019
Ambient Pollution-related Reprogramming of the Human Small Airway Epithelial Transcriptome.. 198. 2018
Ontogeny and Biology of Human Small Airway Epithelial Club Cells.. 198. 2018
Future Research Directions in Pneumonia. NHLBI Working Group Report.. 198. 2018
At the Root: Defining and Halting Progression of Early Chronic Obstructive Pulmonary Disease.. 197. 2018
Update in Chronic Obstructive Pulmonary Disease 2017.. 197. 2018
Obstructive Sleep Apnea Severity Affects Amyloid Burden in Cognitively Normal Elderly. A Longitudinal Study.. 197. 2018
Preponderance of High-Grade Histologic Subtype in Autologous Metastases in Lung Adenocarcinoma.. 197. 2018
High-Attenuation Areas on Chest Computed Tomography and Clinical Respiratory Outcomes in Community-Dwelling Adults.. 196. 2017
A Standardized Diagnostic Ontology for Fibrotic Interstitial Lung Disease. An International Working Group Perspective.. 196. 2017
Serum Matrix Metalloproteinase-7, Respiratory Symptoms, and Mortality in Community-Dwelling Adults. MESA (Multi-Ethnic Study of Atherosclerosis).. 196. 2017
The "Iron"-y of Iron Overload and Iron Deficiency in Chronic Obstructive Pulmonary Disease.. 196. 2017
Occupational Exposures and Subclinical Interstitial Lung Disease. The MESA (Multi-Ethnic Study of Atherosclerosis) Air and Lung Studies.. 196. 2017
The Voice of Surrogate Decision-Makers. Family Responses to Prognostic Information in Chronic Critical Illness.. 196. 2017
NLRP3 Inflammasome Deficiency Protects against Microbial Sepsis via Increased Lipoxin B₄ Synthesis.. 196. 2017
Smoking-Dependent Distal-to-Proximal Repatterning of the Adult Human Small Airway Epithelium.. 196. 2017
A Pilot Study Linking Endothelial Injury in Lungs and Kidneys in Chronic Obstructive Pulmonary Disease.. 195. 2017
Outcomes after Rehospitalization at the Same Hospital or a Different Hospital Following Critical Illness.. 195. 2017
AJRCCM: 100-Year Anniversary. Progress in Interstitial Lung Disease.. 195. 2017
Biomarkers Predictive of Exacerbations in the SPIROMICS and COPDGene Cohorts.. 195. 2017
SPIROMICS Protocol for Multicenter Quantitative Computed Tomography to Phenotype the Lungs.. 194. 2016
Pulmonary Abnormalities in Young, Light-Use Waterpipe (Hookah) Smokers.. 194. 2016
Gut Microbiota Predict Pulmonary Infiltrates after Allogeneic Hematopoietic Cell Transplantation.. 194. 2016
Quantitative IFN-γ and IL-2 Response Associated with Latent Tuberculosis Test Discordance in HIV-infected Pregnant Women.. 193. 2016
IFN-γ-Producing T-Helper 17.1 Cells Are Increased in Sarcoidosis and Are More Prevalent than T-Helper Type 1 Cells.. 193. 2016
Rhinovirus Detection in Symptomatic and Asymptomatic Children: Value of Host Transcriptome Analysis.. 193. 2016
What is Legionnaires' Disease?. 193. 2016
Rising Billing for Intermediate Intensive Care among Hospitalized Medicare Beneficiaries between 1996 and 2010.. 193. 2016
Pulmonary Microvascular Blood Flow in Mild Chronic Obstructive Pulmonary Disease and Emphysema. The MESA COPD Study.. 192. 2015
Detection of Rheumatoid Arthritis-Interstitial Lung Disease Is Enhanced by Serum Biomarkers.. 191. 2015
Indications and Effects of Plasma Transfusions in Critically Ill Children.. 191. 2015
Chronic Infection by Mucoid Pseudomonas aeruginosa Associated with Dysregulation in T-Cell Immunity to Outer Membrane Porin F.. 191. 2015
The impact of the organization of high-dependency care on acute hospital mortality and patient flow for critically ill patients.. 191. 2015
Airway basal cells. The "smoking gun" of chronic obstructive pulmonary disease.. 190. 2014
Insomnia.. 190. 2014
Estimates of the need for palliative care consultation across united states intensive care units using a trigger-based model.. 189. 2014
Loss of salmeterol bronchoprotection against exercise in relation to ADRB2 Arg16Gly polymorphism and exhaled nitric oxide.. 188. 2013
Syndecan-2 exerts antifibrotic effects by promoting caveolin-1-mediated transforming growth factor-β receptor I internalization and inhibiting transforming growth factor-β1 signaling.. 188. 2013
Lymphangioleiomyomatosis: calling it what it is: a low-grade, destructive, metastasizing neoplasm.. 186. 2012
A placebo-controlled randomized trial of warfarin in idiopathic pulmonary fibrosis.. 186. 2012
Poloxamer 188 facilitates the repair of alveolus resident cells in ventilator-injured lungs.. 184. 2011
Comparison of medical admissions to intensive care units in the United States and United Kingdom.. 183. 2011
Circulating endothelial microparticles as a measure of early lung destruction in cigarette smokers.. 184. 2011
HIV infection and risk for incident pulmonary diseases in the combination antiretroviral therapy era.. 183. 2010
Threshold of biologic responses of the small airway epithelium to low levels of tobacco smoke.. 182. 2010
Prognostic importance of hyponatremia in patients with acute pulmonary embolism.. 182. 2010
Noninfectious pneumonitis after everolimus therapy for advanced renal cell carcinoma.. 182. 2010
Clinical predictors of a diagnosis of idiopathic pulmonary fibrosis.. 181. 2010
Use of intensive care services during terminal hospitalizations in England and the United States.. 180. 2009
Genetic risk factors for portopulmonary hypertension in patients with advanced liver disease.. 179. 2009
Down-regulation of the notch pathway in human airway epithelium in association with smoking and chronic obstructive pulmonary disease.. 179. 2008
The prognostic value of cardiopulmonary exercise testing in idiopathic pulmonary fibrosis.. 179. 2008
Potential value of regionalized intensive care for mechanically ventilated medical patients.. 177. 2007
Variable prostaglandin E2 resistance in fibroblasts from patients with usual interstitial pneumonia.. 177. 2007
Diffuse lung disease in young children: application of a novel classification scheme.. 176. 2007
Impaired flow-mediated dilation is associated with low pulmonary function and emphysema in ex-smokers: the Emphysema and Cancer Action Project (EMCAP) Study.. 176. 2007
Early interstitial lung disease in familial pulmonary fibrosis.. 176. 2007
Intermittent hypoxia causes insulin resistance in lean mice independent of autonomic activity.. 175. 2007
Idiopathic interstitial pneumonia: do community and academic physicians agree on diagnosis?. 175. 2007
Idiopathic pulmonary fibrosis: prognostic value of changes in physiology and six-minute-walk test.. 174. 2006
Progress and new directions in genetics of tuberculosis: an NHLBI working group report.. 172. 2005
The association of acetaminophen, aspirin, and ibuprofen with respiratory disease and lung function.. 171. 2005
Physiology is a stronger predictor of survival than pathology in fibrotic interstitial pneumonia.. 171. 2005
Idiopathic interstitial pneumonia: what is the effect of a multidisciplinary approach to diagnosis?. 170. 2004
Enhanced monocyte chemoattractant protein-3/CC chemokine ligand-7 in usual interstitial pneumonia.. 170. 2004
Relationship of serum antioxidants to asthma prevalence in youth.. 169. 2003
Sitaxsentan therapy for pulmonary arterial hypertension.. 169. 2003
Maximal oxygen uptake and severity of disease in lymphangioleiomyomatosis.. 168. 2003
Prognostic value of desaturation during a 6-minute walk test in idiopathic interstitial pneumonia.. 168. 2003
Prognostic implications of physiologic and radiographic changes in idiopathic interstitial pneumonia.. 168. 2003
Fibroblastic foci in usual interstitial pneumonia: idiopathic versus collagen vascular disease.. 167. 2003
Bleomycin-induced pulmonary fibrosis is attenuated in gamma-glutamyl transpeptidase-deficient mice.. 167. 2002
Future research directions in idiopathic pulmonary fibrosis: summary of a National Heart, Lung, and Blood Institute working group.. 166. 2002
Histopathologic variability in usual and nonspecific interstitial pneumonias.. 164. 2001
Reversible airflow obstruction, proliferation of abnormal smooth muscle cells, and impairment of gas exchange as predictors of outcome in lymphangioleiomyomatosis.. 164. 2001
Preserved spontaneous breathing improves cardiac output during partial liquid ventilation.. 164. 2001
Human collagenase (matrix metalloproteinase-1) expression in the lungs of patients with emphysema.. 163. 2001
Classification of sleep-disordered breathing.. 163. 2001
Differential patterns of apoptosis in resolving and nonresolving bacterial pneumonia.. 161. 2000
Increase of lung neutrophils in hypersensitivity pneumonitis is associated with lung fibrosis.. 161. 2000
Downregulation of estrogen and progesterone receptors in the abnormal smooth muscle cells in pulmonary lymphangioleiomyomatosis following therapy. An immunohistochemical study.. 161. 2000
Feasibility of a clinical trial of augmentation therapy for alpha(1)-antitrypsin deficiency. The Alpha 1-Antitrypsin Deficiency Registry Study Group.. 161. 2000
Fine mapping of PPH1, a gene for familial primary pulmonary hypertension, to a 3-cM region on chromosome 2q33.. 161. 2000
The utility of open lung biopsy in patients with hematologic malignancies.. 161. 2000
Outcomes after long-term acute care. An analysis of 133 mechanically ventilated patients.. 159. 1999
Analysis of risk factors for the development of bronchiolitis obliterans syndrome.. 159. 1999
Acidosis stimulates nitric oxide production and lung damage in rats.. 159. 1999
Outcomes and resource utilization for patients with prolonged critical illness managed by university-based or community-based subspecialists.. 158. 1998
Severe community-acquired pneumonia. Assessment of severity criteria.. 158. 1998
Acute respiratory distress syndrome caused by pulmonary and extrapulmonary disease. Different syndromes?. 158. 1998
Survival and FEV1 decline in individuals with severe deficiency of alpha1-antitrypsin. The Alpha-1-Antitrypsin Deficiency Registry Study Group.. 158. 1998
A "closed" medical intensive care unit (MICU) improves resource utilization when compared with an "open" MICU.. 157. 1998
Do molecular markers predict survival in non-small-cell lung cancer?. 157. 1998
Risk of tuberculin conversion according to occupation among health care workers at a New York City hospital.. 156. 1997
Lack of clinical utility of bronchoalveolar lavage cultures for cytomegalovirus in HIV infection.. 155. 1997
Neutrophil rheologic changes in septic shock.. 155. 1997
Activated neutrophils secrete stored alpha 1-antitrypsin.. 154. 1996
Clinical features of individuals with PI*SZ phenotype of alpha 1-antitrypsin deficiency. alpha 1-Antitrypsin Deficiency Registry Study Group.. 154. 1996
Increased expression of gelatinases and collagenase in rat lungs exposed to 100% oxygen.. 154. 1996
Quantitative assessment of the epithelial and inflammatory cell populations in large airways of normals and individuals with cystic fibrosis.. 153. 1996
Relationship between procedures and health insurance for critically ill patients with Pneumocystis carinii pneumonia.. 152. 1995
Guidelines for the initial management of community-acquired pneumonia: savory recipe or cookbook for disaster?. 152. 1995
Supplemental oxygen during sleep in children with sleep-disordered breathing.. 152. 1995
Transmission of multidrug-resistant tuberculosis in a large urban setting.. 152. 1995
Radiologic evaluation of emphysema in patients with chronic obstructive pulmonary disease. Chest radiography versus high resolution computed tomography.. 151. 1995
Chemotherapeutic activity of clofazimine and its analogues against Mycobacterium tuberculosis. In vitro, intracellular, and in vivo studies.. 151. 1995
A rapid preadmission method for predicting inpatient course of disease for patients with HIV-related Pneumocystis carinii pneumonia.. 150. 1994
Invasive diagnostic testing is not needed routinely to manage suspected ventilator-associated pneumonia.. 150. 1994
Protease-antiprotease imbalance in the lungs of children with cystic fibrosis.. 150. 1994
Pulmonary function abnormalities in thalassemia major and the role of iron overload.. 149. 1994
Reply to Moor et al. and Egashira et al.. 212. 2026
Reply to Hua et al.: The Driving Pressure Setting of Acute Respiratory Distress Syndrome: Beyond the Age.. 211. 2025
Exercise Limitation in Pulmonary Hypertension - Physiological Insights into the 6-Minute Walk Test.. 210. 2024
Trends in Sedative Prescription among Older Adults after Critical Illness: A Population-based Cohort Study.. 210. 2024
TOLLIP SNP and Antimicrobial Treatment Effect in Idiopathic Pulmonary Fibrosis.. 210. 2024
Early Mortality in Clinical Trials of Acute Respiratory Distress Syndrome.. 210. 2024
Reply by Elmaleh-Sachs et al. to Townsend and Cowl, and to Miller et al.. 206. 2022
Obstructive Sleep Apnea and Hypertension with Longitudinal Amyloid-β Burden and Cognitive Changes.. 206. 2022
Pulmonary Arterial Hypertension: Diagnosis, Treatment, and Novel Advances.. 203. 2021
Prediction of Health-related Quality of Life and Hospitalization in Pulmonary Arterial Hypertension: The Pulmonary Hypertension Association Registry.. 203. 2021
Effect of Neutropenic Critical Illness on Development and Prognosis of Acute Respiratory Distress Syndrome.. 203. 2021
Reply to Sharma and Zeki: Does Vaping Increase Susceptibility to COVID-19?. 202. 2020
A Novel Viral Epidemic Collides with an Ancient Scourge: COVID-19 Associated with Tuberculosis.. 202. 2020
Alveolar Macrophage Immunometabolism and Lung Function Impairment in Smoking and Chronic Obstructive Pulmonary Disease.. 201. 2020
Which Biopsy to Diagnose Interstitial Lung Disease? A Call for Evidence and Unity.. 200. 2019
Importance of Mcl-1 for Alveolar Macrophage Apoptosis-associated Bacterial Killing.. 200. 2019
A Bulging Chest Wall Mass after Pneumococcal Empyema. A Case of Pneumothorax Necessitans.. 199. 2019
Evaluation of the 2016 Infectious Diseases Society of America/American Thoracic Society Guideline Criteria for Risk of Multidrug-Resistant Pathogens in Patients with Hospital-acquired and Ventilator-associated Pneumonia in the ICU.. 197. 2018
Patient-centered Outcomes in Idiopathic Pulmonary Fibrosis Clinical Trials.. 196. 2017
Novel Discoveries and Advances in Management of Acute Respiratory Distress Syndrome.. 195. 2017
Distinct Serum Sphingolipid Profiles among School-aged Children with Exercise-induced Wheeze and Asthma Persistence.. 195. 2017
New Evidence for the Complexity of the Population Structure of Mycobacterium tuberculosis Increases the Diagnostic and Biologic Challenges.. 194. 2016
Long-Term Outcomes after Critical Illness. The Best Predictor of the Future Is the Past.. 194. 2016
Cigarette Smoking Induces Changes in Airway Epithelial Expression of Genes Associated with Monogenic Lung Disorders.. 193. 2016
Severe Cavitary, Fistulating Mycobacterium avium-intracellulare Complex Disease in an Immunocompetent Host.. 192. 2015
Intensivist workforce in the United States: the crisis is real, not imagined.. 191. 2015
Airway Basal stem/progenitor cells have diminished capacity to regenerate airway epithelium in chronic obstructive pulmonary disease.. 190. 2014
Reply: Palliative care: a core competency for intensive care unit doctors.. 189. 2014
Changes in physician reimbursement by medicare for critical care services from 1998 to 2008.. 188. 2013
Reply: Characterization of lymphangioleiomyomatosis as a neoplastic disease.. 188. 2013
Reversible cystic lesions of Pneumocystis jirovecii pneumonia.. 185. 2012
Risk and incidence of pulmonary diseases among HIV-infected patients in the era of combination antiretroviral therapy.. 184. 2011
Shock and pulmonary edema secondary to severe acute hypercapnic acidosis.. 184. 2011
Are physicians' recommendations on limiting life support really burdensome?. 181. 2010
Surgical lung biopsy in the diagnosis of idiopathic NSIP: do we always need it in the initial approach?. 179. 2009
Lung transplantation: opportunities for research and clinical advancement.. 173. 2006
Acute eosinophilic pneumonia in a New York City firefighter exposed to World Trade Center dust.. 166. 2002
Recurrence of desquamative interstitial pneumonia after lung transplantation.. 156. 1997
Oh to Be Watched Over by Machines of Loving Grace: Promise and Pitfalls of Quantitative Computed Tomography in Early Interstitial Lung Disease Detection.. 211. 2025
Watching an Evolution in Progress, Cutting-Edge Research Transforming Outcomes in Interstitial Lung Disease: Introduction to an AJRCCM Special Section.. 211. 2025
Big Things Have Small Beginnings: Clinical Implications of Early Interstitial Lung Disease.. 210. 2024
Bystander No More: Small Airway Involvement in Idiopathic Pulmonary Fibrosis.. 210. 2024
Pioneering Research Driving Progress toward a Cure for Interstitial Lung Disease (ILD): Introduction to the AJRCCM Special Issue on ILD (Part 2).. 210. 2024
Monotherapy or Combination Therapy for Septic Shock? A Debate on Steroids.. 209. 2024
Watching an Evolution in Progress, Cutting-Edge Research Transforming Outcomes in Interstitial Lung Disease: Introduction to an AJRCCM Special Issue.. 209. 2024
A Lipid Map for Community-acquired Pneumonia with Sepsis: Observation Is the First Step in Scientific Progress.. 209. 2024
Critical Care: A Second Special Issue of the Blue Journal.. 209. 2024
Critical Care: A Special Issue of the Blue Journal.. 209. 2024
Are Airway Epithelial p73 Levels a Therapeutic Target to Treat Chronic Obstructive Pulmonary Disease?. 209. 2024
CEACAM6: A Novel Marker of Chronic Obstructive Pulmonary Disease Susceptibility?. 207. 2023
"KEAP"ing Alveolar Macrophage Mitochondria Content in Chronic Obstructive Pulmonary Disease.. 207. 2023
Understanding the People Excluded from Chronic Obstructive Pulmonary Disease Clinical Trials.. 206. 2022
Premature Aging of the Airway Epithelium in Chronic Obstructive Pulmonary Disease in People Living with HIV.. 206. 2022
What COVID-19 Has Taught Us: Ventilator-associated Pneumonia Is Back!. 206. 2022
Inequity and the Interstitium: Pushing Back on Disparities in Fibrosing Lung Disease in the United States and Canada.. 205. 2022
Inhaled Corticosteroid Use in Early Childhood: A Risk for High Body Mass Index?. 204. 2021
The Saga of Necroptosis in Chronic Obstructive Pulmonary Disease Continues.. 204. 2021
Pinpointing the Cause of Variation in Mortality in COVID-19.. 204. 2021
More Evidence for Inborn Dysregulation of Sphingolipid Metabolism in Children with Asthma?. 203. 2021
Antibiotic Use in Sepsis: How and Why Less Can Really Mean More (Survival).. 203. 2021
COVID-19 and Interstitial Lung Disease: Keep Them Separate.. 202. 2020
The Origins of Chronic Obstructive Pulmonary Disease: Sometimes the Journey Matters More than the Destination.. 202. 2020
Mechanical Ventilation in COVID-19: Interpreting the Current Epidemiology.. 202. 2020
Rising to the Challenge of COVID-19: Advice for Pulmonary and Critical Care and an Agenda for Research.. 201. 2020
When Intensive Care Becomes Good End-of-Life Care.. 201. 2020
Determination of Early Immune Function in Sepsis and Its Influence on Organ Dysfunction. Is a More Pragmatic Outcome on the Horizon?. 198. 2018
Manmade Macrophage Offers a New Therapy for Pulmonary Alveolar Proteinosis.. 198. 2018
Seeing Deeply into the Lung in Interstitial Lung Disease.. 197. 2018
Circulating Mitochondrial DNA as a Mechanism-based, Prognostic Biomarker for Idiopathic Pulmonary Fibrosis.. 196. 2017
Midkine: In the Middle of the Pathogenesis of Acute Respiratory Distress Syndrome-associated Lung Fibrosis?. 192. 2015
Insights into intensive care unit bed expansion in the United States. National and regional analyses.. 191. 2015
Untangling the healthcare use patterns of severe sepsis survivors.. 190. 2014
Are the smoking-induced diseases an acquired form of cystic fibrosis?. 188. 2013
The IPFnet Strategy: Creating a comprehensive approach in the treatment of idiopathic pulmonary fibrosis.. 181. 2010
Inducible nitric oxide synthase in the tuberculous human lung.. 166. 2002
On the contagious nature of tuberculosis (continued).. 165. 2002
Approach to the Evaluation and Management of Interstitial Lung Abnormalities: An Official American Thoracic Society Clinical Statement. 2025
Genetics and Genomics of Pulmonary Fibrosis: Charting the Molecular Landscape and Shaping Precision Medicine. 2024
From ICU Syndromes to ICU Subphenotypes: Consensus Report and Recommendations for Developing Precision Medicine in the ICU. 2024
Effectiveness of Fludrocortisone Plus Hydrocortisone versus Hydrocortisone Alone in Septic Shock: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials. 2024
Treatment of Systemic Sclerosis-associated Interstitial Lung Disease: Evidence-based Recommendations. An Official American Thoracic Society Clinical Practice Guideline. 2024
Prevalence, Risk Factors, and Outcomes of Adult Interstitial Lung Abnormalities: A Systematic Review and Meta-Analysis. 2023
Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline. 2022
Update in Interstitial Lung Disease 2020. 2021
Update in Critical Care 2020. 2021
Female Sex and Gender in Lung/Sleep Health and Disease. Increased Understanding of Basic Biological, Pathophysiological, and Behavioral Mechanisms Leading to Better Health for Female Patients with Lung Disease. 2018
The Low-Risk Profile in Pulmonary Arterial Hypertension. Time for a Paradigm Shift to Goal-oriented Clinical Trial Endpoints? 2018
The Role of Danger Signals in the Pathogenesis and Perpetuation of Critical Illness. 2018
Update in Critical Care 2016. 2017
Enhancing Insights into Pulmonary Vascular Disease through a Precision Medicine Approach. A Joint NHLBI-Cardiovascular Medical Research and Education Fund Workshop Report. 2017
An Official American Thoracic Society/European Society of Intensive Care Medicine/Society of Critical Care Medicine Clinical Practice Guideline: Mechanical Ventilation in Adult Patients with Acute Respiratory Distress Syndrome. 2017
An Official American Thoracic Society Systematic Review: The Effect of Nighttime Intensivist Staffing on Mortality and Length of Stay among Intensive Care Unit Patients. 2017
The non-small cell lung cancer immune contexture. A major determinant of tumor characteristics and patient outcome. 2015
The role of stepdown beds in hospital care. 2014
An official American Thoracic Society/American Association of Critical-Care Nurses/American College of Chest Physicians/Society of Critical Care Medicine policy statement: the Choosing Wisely® Top 5 list in Critical Care Medicine. 2014
An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. 2013
IFN-γ release assays in the diagnosis of latent tuberculosis infection among immunocompromised adults. 2013
Genome-wide association studies identify CHRNA5/3 and HTR4 in the development of airflow obstruction. 2012
Update in respiratory infections 2011. 2012
Chronic critical illness. 2010
Idiopathic nonspecific interstitial pneumonia: report of an American Thoracic Society project. 2008
Acute exacerbations of idiopathic pulmonary fibrosis. 2007
American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. 2002
NHLBI Workshop Summary. Report of workshop on lymphangioleiomyomatosis. National Heart, Lung, and Blood Institute. 1999
Pulmonary cell biology. 1998
Standards and indications for cardiopulmonary sleep studies in children. American Thoracic Society. 1996
Gene therapy for the respiratory manifestations of cystic fibrosis. 1995

VIVO Weill Cornell Medical College

American journal of respiratory and critical care medicine Journal

Overview

publication venue for

Identity

ISO Abbreviation

Linking ISSN

International Standard Serial Number (ISSN)

Electronic International Standard Serial Number (EISSN)